• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Faeth Therapeutics, Inc. - Common Stock (NQ:FTH)

    34.16 +1.39 (+4.24%)
    Streaming Delayed Price Updated: 11:24 AM EDT, Sep 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 35,712
    Open 33.44
    Bid (Size) 33.92 (200)
    Ask (Size) 34.16 (100)
    Prev. Close 32.77
    Today's Range 33.00 - 34.92
    52wk Range 13.43 - 37.90
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Faeth Therapeutics to Participate in Upcoming September Investor Conferences
    From Faeth Therapeutics
    Via Business Wire
    News headline image
    Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Faeth Therapeutics, Inc.
    Via Business Wire

    Performance

    YTD
    +135.1%
    +135.1%
    1 Month
    +24.9%
    +24.9%
    3 Month
    +135.1%
    +135.1%
    6 Month
    +135.1%
    +135.1%
    1 Year
    +135.1%
    +135.1%

    More News

    Read More
    News headline image
    Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
    From Faeth Therapeutics
    Via Business Wire
    News headline image
    Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
    From Faeth Therapeutics, Inc.
    Via Business Wire
    News headline image
    Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Faeth Therapeutics, Inc.
    Via Business Wire
    News headline image
    Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference
    From Faeth Therapeutics
    Via Business Wire
    News headline image
    Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates
    From Faeth Therapeutics
    Via Business Wire
    News headline image
    Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Faeth Therapeutics, Inc.
    Via Business Wire
    News headline image
    Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Faeth Therapeutics, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Faeth Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Faeth Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Faeth Therapeutics, Inc. - Common Stock trade on?
    Faeth Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Faeth Therapeutics, Inc. - Common Stock?
    The ticker symbol for Faeth Therapeutics, Inc. - Common Stock is FTH on the Nasdaq Stock Market
    What is the current price of Faeth Therapeutics, Inc. - Common Stock?
    The current price of Faeth Therapeutics, Inc. - Common Stock is 34.16
    When was Faeth Therapeutics, Inc. - Common Stock last traded?
    The last trade of Faeth Therapeutics, Inc. - Common Stock was at 09/01/26 11:24 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.